The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines
Open accessAbstract
Mortality from coronavirus disease 2019 (COVID-19) in populations at high risk, such as the elderly, certain ethnic groups (e.g., Black/African American, and Hispanic/Latino persons), obese individuals, and those with endothelial dysfunction is substantial. While treatment options are limited, vaccination against SARS-CoV-2, the virus that causes COVID-19, is the most important global strategy in controlling the pandemic. Thus, two lipid nanoparticle (LNP)-based mRNA vaccines (Pfizer-BioNTech and Moderna) against SARS-CoV-2 have already received emergency use authorization by the US Food and Drug Administration (FDA).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retraction for Pushparaj et al., The cytokine interleukin-33 mediates anaphylactic shock
(2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210844109 · Cited by 4
RetractedThe pathophysiology of anaphylaxis
Reber, L. L., Hernandez, J. D., & Galli, S. J. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.06.003 · Cited by 534
CDC COVID-19 Response Team, & Administration, F. A. D. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7002e1 · Cited by 481
Rüggeberg, J. U., Gold, M., Bayas, J. M., Blum, M. D., Bonhoeffer, J., Friedlander, S. F., Brito, G. D. S., Heininger, U., Imoukhuede, E. B., Khamesipour, A., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.064 · Cited by 383
Risk of anaphylaxis after vaccination in children and adults.
McNeil, M. M., Weintraub, E. S., Duffy, J., Sukumaran, L., Jacobsen, S. J., Klein, N. P., Hambidge, S. J., Lee, G. M., Jackson, L. A., Irving, S. A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.07.048 · Cited by 381
Pathways of anaphylaxis in the mouse.
Strait, R., Morris, S., Yang, M.-Y., Qu, X.-W., & Finkelman, F. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.123302 · Cited by 326
Ganson, N. J., Povsic, T. J., Sullenger, B. A., Alexander, J. H., Zelenkofske, S. L., Sailstad, J. M., Rusconi, C. P., & Hershfield, M. S. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.034 · Cited by 275
CDC COVID-19 Response Team, & Administration, F. A. D. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7004e1 · Cited by 270
Wibroe, P. P., Ahmadvand, D., Oghabian, M. A., Yaghmur, A., & Moghimi, S. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.021 · Cited by 203
Polyvinyl Pyrrolidone as a Plasma Expander
Ravin, H. A., Seligman, A. M., & Fine, J. (1952) · New England Journal of Medicine · doi:10.1056/nejm195212112472403 · Cited by 196
Anti-PEG IgE in anaphylaxis associated with polyethylene glycol
Zhou, Z., Stone, C. A., Jakubovic, B. D., Phillips, E. J., Sussman, G., Park, J., Hoang, U., Kirshner, S., Levin, R. L., & Kozlowski, S. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.11.011 · Cited by 134
N 1-Methylpseudouridine substitution enhances the performance of synthetic mRNA switches in cells
Parr, C., Wada, S., Kotake, K., Kameda, S., Matsuura, S., Sakashita, S., Park, S., Sugiyama, H., Kuang, Y., & Saito, H. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa070 · Cited by 121
Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination
Torjesen, I. (2021) · BMJ · doi:10.1136/bmj.n149 · Cited by 108
Moghimi, S. M., Simberg, D., Papini, E., & Farhangrazi, Z. S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.012 · Cited by 75
Moghimi, S. M. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00273-4 · Cited by 72
Moghimi, S. M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.11.006 · Cited by 72
Suspicions grow that nanoparticles in Pfizer's COVID-19 vaccine trigger rare allergic reactions
(2020) · AAAS Articles DO Group · doi:10.1126/science.abg2359 · Cited by 56
Anaphylaxis after hepatitis B vaccination
Lear, J. T., & English, J. S. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92039-0 · Cited by 55
Tuning the Engines of Nanomedicine
Moghimi, S. M., Simberg, D., & Anchordoquy, T. J. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.025 · Cited by 8
Cited by
Sorted by citations
The dawn of mRNA vaccines: the COVID-19 case
Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.043 · Cited by 504
COVID-19 vaccine development: milestones, lessons and prospects
Li, M., Wang, H., Tian, L., Pang, Z., Yang, Q., Huang, T., Fan, J., Song, L., Tong, Y., & Fan, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00996-y · Cited by 478
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Trougakos, I. P., Terpos, E., Alexopoulos, H., Politou, M., Paraskevis, D., Scorilas, A., Kastritis, E., Andreakos, E., & Dimopoulos, M. A. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.04.007 · Cited by 273
Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy
You, Y., Tian, Y., Yang, Z., Shi, J., Kwak, K. J., Tong, Y., Estania, A. P., Cao, J., Hsu, W.-H., Liu, Y., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00989-w · Cited by 258
Domingues, C., Santos, A., Alvarez-Lorenzo, C., Concheiro, A., Jarak, I., Veiga, F., Barbosa, I., Dourado, M., & Figueiras, A. (2022) · ACS Nano · doi:10.1021/acsnano.2c00128 · Cited by 235
Metadata
- Authors
- Moghimi, S. M.
- Affiliations
- Newcastle University (GB)
- Corresponding author
- Moghimi, S. Moein
- ORCID
- Moghimi, S. Moein
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 29
- Issue
- 3
- Pages
- 898-900
- ISSN
- 1525-0016 (ISSN-L)
- PMC
- PMC7862013
- OpenAlex
- W3126797562
- Cited by
- 150
- References
- 19
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 33 · 2023: 33 · 2022: 32 · 2021: 20
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Therapy (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- allergic reactions, anaphylaxis, COVID-19 vaccines, SARS-CoV-2, BNT162b2, Moderna vaccine, vaccine safety, emergency use authorization
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, mRNA Vaccines, BNT162 Vaccine, 2019-nCoV Vaccine mRNA-1273, Amino Alcohols, Anaphylaxis, Decanoates, Excipients, Humans, Liposomes, Polyethylene Glycols, Vaccines, Synthetic, Mass Vaccination, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
